Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Medicinova Inc.(MNOV US)

$1.40-0.010.36%Ext:$1.59+0.1913.98%(Market Closed ยท 00:55:25 UTC)
Doc SearchProfileEntity StructureEDINET FilingsFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner
EDINET Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Medicinova Inc.(MNOV US)

$1.40-0.010.36%Ext:$1.59+0.1913.98%(Market Closed ยท 00:55:25 UTC)
Doc SearchProfileEntity StructureEDINET FilingsFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner
EDINET Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
MNOV USโ€‹
Ask AI
MNOV USโ€‹
Ask AI

Chronological SEC Filings

Chronological SEC Filings

Non-Ownership Filings(528)

Expand
  • 10-QQ3ended 30 Sept 202612 Nov
  • 8-KEntry into a Material Definitive Agreement28 Sep
  • 8-KTermination of a Material Definitive Agreement2 Sep
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers19 Aug
  • 10-QQ2ended 30 Jun 202613 Aug
  • 8-KSubmission of Matters to a Vote of Security Holders24 Jun
  • 10-QQ1ended 31 Mar 202614 May
  • ARSAnnual report to security holders29 Apr
  • DEFA14ADefinitive additional materials29 Apr
  • DEF 14ADefinitive proxy statement29 Apr
  • PRER14APreliminary proxy statement (revision)20 Apr
  • PRE 14APreliminary proxy statement17 Apr
  • 10-KFY 2025ended 31 Dec 202510 Mar
  • 8-KUnaudited Consolidated Financial Results20 Feb
  • 424B5Prospectus filing (Rule 424(b)(5))30 Dec 2025
  • 8-KEntry into a Material Definitive Agreement30 Dec 2025
  • EFFECTNotice of effectiveness12 Dec 2025
  • CORRESPFiling review correspondence9 Dec 2025
  • S-3Registration statement (primary offering)5 Dec 2025
  • 10-QQ3ended 30 Sept 202512 Nov 2025

Ownership Filings(338)

Expand
  • SC 13GMEDICINOVA INC30 Oct
  • Form 43D Opportunity Master Fund29 Sep
  • SC 13D/AMEDICINOVA INC29 Sep
  • Form 4Nagao Hideki25 Jun
  • Form 4Lemerond Nicole25 Jun
  • Form 4BEAVER CAROLYN25 Jun
  • Form 4Matsuda Kazuko20 Jan
  • Form 4IWAKI YUICHI20 Jan
  • Form 4Nagao Hideki20 Jun 2025
  • Form 4Lemerond Nicole20 Jun 2025
  • Form 4BEAVER CAROLYN20 Jun 2025
  • Form 4Nagao Hideki14 Feb 2025
  • Form 4Matsuda Kazuko14 Feb 2025
  • Form 4Lemerond Nicole14 Feb 2025
  • Form 4IWAKI YUICHI14 Feb 2025
  • Form 4BEAVER CAROLYN14 Feb 2025
  • Form 4IWAKI YUICHI10 Jan 2025
  • Form 4Matsuda Kazuko10 Jan 2025
  • Form 4Lemerond Nicole12 Jun 2024
  • Form 4BEAVER CAROLYN12 Jun 2024

Non-Ownership Filings(528)

Expand
  • 10-QQ3ended 30 Sept 202612 Nov
  • 8-KEntry into a Material Definitive Agreement28 Sep
  • 8-KTermination of a Material Definitive Agreement2 Sep
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers19 Aug
  • 10-QQ2ended 30 Jun 202613 Aug
  • 8-KSubmission of Matters to a Vote of Security Holders24 Jun
  • 10-QQ1ended 31 Mar 202614 May
  • ARSAnnual report to security holders29 Apr
  • DEFA14ADefinitive additional materials29 Apr
  • DEF 14ADefinitive proxy statement29 Apr
  • PRER14APreliminary proxy statement (revision)20 Apr
  • PRE 14APreliminary proxy statement17 Apr
  • 10-KFY 2025ended 31 Dec 202510 Mar
  • 8-KUnaudited Consolidated Financial Results20 Feb
  • 424B5Prospectus filing (Rule 424(b)(5))30 Dec 2025
  • 8-KEntry into a Material Definitive Agreement30 Dec 2025
  • EFFECTNotice of effectiveness12 Dec 2025
  • CORRESPFiling review correspondence9 Dec 2025
  • S-3Registration statement (primary offering)5 Dec 2025
  • 10-QQ3ended 30 Sept 202512 Nov 2025

Ownership Filings(338)

Expand
  • SC 13GMEDICINOVA INC30 Oct
  • Form 43D Opportunity Master Fund29 Sep
  • SC 13D/AMEDICINOVA INC29 Sep
  • Form 4Nagao Hideki25 Jun
  • Form 4Lemerond Nicole25 Jun
  • Form 4BEAVER CAROLYN25 Jun
  • Form 4Matsuda Kazuko20 Jan
  • Form 4IWAKI YUICHI20 Jan
  • Form 4Nagao Hideki20 Jun 2025
  • Form 4Lemerond Nicole20 Jun 2025
  • Form 4BEAVER CAROLYN20 Jun 2025
  • Form 4Nagao Hideki14 Feb 2025
  • Form 4Matsuda Kazuko14 Feb 2025
  • Form 4Lemerond Nicole14 Feb 2025
  • Form 4IWAKI YUICHI14 Feb 2025
  • Form 4BEAVER CAROLYN14 Feb 2025
  • Form 4IWAKI YUICHI10 Jan 2025
  • Form 4Matsuda Kazuko10 Jan 2025
  • Form 4Lemerond Nicole12 Jun 2024
  • Form 4BEAVER CAROLYN12 Jun 2024